Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

A woman with severe angioedema improved significantly after treatment with rituximab.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Bioengineered salivary glands in mice can produce saliva when tasting sour or bitter, but have different protein levels and nerve signals compared to natural glands.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

The document concludes that regenerating functional ectodermal organs like teeth and hair is promising for future therapies.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Iron deficiency might contribute to hair loss in women.